Bellevue Life Sciences Acquisition (BLAC) Short Interest Ratio & Short Volume

Short interest is the volume of Bellevue Life Sciences Acquisition shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 100 shares of BLAC short. Learn More on Bellevue Life Sciences Acquisition's current short interest.

Bellevue Life Sciences Acquisition currently has issued a total of 4,040,000 shares. Some of Bellevue Life Sciences Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bellevue Life Sciences Acquisition currently has a public float of 3,520,000 shares.

Here is how the short interest of companies in the industry of "medical equipment" compare to Bellevue Life Sciences Acquisition: The Beauty Health Company (11.00%), KORU Medical Systems, Inc. (1.13%), BrainsWay Ltd. (0.23%), Alpha Tau Medical Ltd. (0.13%), Lakeland Industries, Inc. (2.11%), Nevro Corp. (8.38%), Jin Medical International Ltd. (2.88%), Pro-Dex, Inc. (0.90%), Sensus Healthcare, Inc. (4.04%), TriSalus Life Sciences, Inc. (1.26%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

Short selling BLAC is an investing strategy that aims to generate trading profit from Bellevue Life Sciences Acquisition as its price is falling. BLAC shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Bellevue Life Sciences Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BLAC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLAC, twice per month. The most recent reporting period available is July, 15 2024.